Obid, Rahib .
HRN: 23-94-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/18/2025
03/25/2025
IV
4.5gm
Q8h
Infectious Endocarditis
Waiting Final Action
Indication: Empiric Type of Infection: Cardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes